Daan Gene: Net loss of 182 million yuan in the first half of 2025, a year-on-year decrease of 54.37%

De'Angen Gene announced that its operating income in the first half of 2025 was 339 million yuan, a decrease of 15.44% year-on-year. Net loss attributable to shareholders of the listed company was 182 million yuan, a decrease of 54.37% year-on-year. The company plans not to distribute cash dividends, bonus shares, or increase capital reserves by converting them into shares.